Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer

Annals of Thoracic Surgery

Volumn 92, Issue 5, 2011, Pages 1794-1804

  Shintani, Yasushi ^a,b   Okimura, Akira ^b   Sato, Katsutoshi ^a   Nakagiri, Tomoyuki ^a   Kadota, Yoshihisa ^a   Inoue, Masayohi ^a   Sawabata, Noriyoshi ^a   Minami, Masato ^a   Ikeda, Naoki ^b   Kawahara, Kunimistu ^b   Matsumoto, Tomoshige ^b   Matsuura, Nariaki ^a   Ohta, Mitsunori ^b   Okumura, Meinoshin ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOKERATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR; MITOMYCIN; NAVELBINE; NERVE CELL ADHESION MOLECULE; PACLITAXEL; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; VINDESINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL SHAPE; CHEMORADIOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SIGNAL TRANSDUCTION; SPINDLE CELL; SURVIVAL RATE; THORACOTOMY; UPREGULATION;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR CELLS, CULTURED;

EID: 80155198451     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2011.07.032     Document Type: Article

References (30)

1. A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392 (Pubitemid 38101633)
2. D.N. Carney Lung cancer - time to move on from chemotherapy N Engl J Med 346 2002 126 128 (Pubitemid 34438905)
3. G. Friedel, W. Budach, and J. Dippon Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study J Clin Oncol 28 2010 942 948
4. W. Weder, S. Collaud, and W.E. Eberhardt Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer J Thorac Cardiovasc Surg 139 2010 1424 1430
5. R.M. Bremnes, R. Veve, and E. Gabrielson High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer J Clin Oncol 20 2002 2417 2428 (Pubitemid 34525727)
6. J.P. Thiery Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 15 2003 740 746 (Pubitemid 37487967)
7. M.J. Wheelock, and K.R. Johnson Cadherins as modulators of cellular phenotype Annu Rev Cell Dev Biol 19 2003 207 235 (Pubitemid 37487348)
8. M.J. Wheelock, Y. Shintani, M. Maeda, Y. Fukumoto, and K.R. Johnson Cadherin switching J Cell Sci 121 Pt 6 2008 727 735 (Pubitemid 351578108)
9. M. Takeichi Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 1991 1451 1455 (Pubitemid 121000430)
10. D. Liu, C. Huang, and K. Kameyama E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer Ann Thorac Surg 71 2001 949 954 (Pubitemid 32210406)
11. M.T. Nieman, R.S. Prudoff, K.R. Johnson, and M.J. Wheelock N-cadherin promotes motility in human breast cancer cells regardless of their e-cadherin expression J Cell Biol 147 1999 631 644
12. M. Maeda, K.R. Johnson, and M.J. Wheelock Cadherin switching: Essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition J Cell Sci 118 Pt 5 2005 873 887 (Pubitemid 40484880)
13. R.M. Bremnes, R. Veve, and E. Gabrielson High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer J Clin Oncol 20 2002 2417 2428 (Pubitemid 34525727)
14. G. Deeb, J. Wang, and N. Ramnath Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry Mod Pathol 17 2004 430 439 (Pubitemid 41646598)
15. A. Soltermann, V. Tischler, and S. Arbogast Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer Clin Cancer Res 14 2008 7430 7437
16. W.L. Zhuo, Y. Wang, X.L. Zhuo, Y.S. Zhang, and Z.T. Chen Short interfering RNA directed against TWIST, a novel zinc finger transcription factor, increases A549 cell sensitivity to cisplatin via MAPK/mitochondrial pathway Biochem Biophys Res Commun 369 2008 1098 1102
17. W. Zhuo, Y. Wang, X. Zhuo, Y. Zhang, X. Ao, and Z. Chen Knockdown of Snail, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway Lung Cancer 62 2008 8 14
18. S. Thomson, E. Buck, and F. Petti Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition Cancer Res 65 2005 9455 9462 (Pubitemid 41508014)
19. G. Del Castillo, M.M. Murillo, and A. Alvarez-Barrientos Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands Exp Cell Res 312 2006 2860 2871
20. Y. Shintani, M. Maeda, N. Chaika, K.R. Johnson, and M.J. Wheelock Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling Am J Respir Cell Mol Biol 38 2008 95 104
21. G. Bertolini, L. Roz, and P. Perego Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment Proc Natl Acad Sci U S A 106 2009 16281 16286
22. K.S. McCarty Jr, E. Szabo, and J.L. Flowers Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors Cancer Res 46 8 Suppl 1986 4244s 4248s (Pubitemid 16041242)
23. J.K. Rho, Y.J. Choi, and J.K. Lee Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line Lung Cancer 63 2009 219 226
24. S.E. Witta, R.M. Gemmill, and F.R. Hirsch Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines Cancer Res 66 2006 944 950 (Pubitemid 43165962)
25. U. Cavallaro, B. Schaffhauser, and G. Christofori Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176 2002 123 128 (Pubitemid 34136010)
26. T. Nakashima, C. Huang, and D. Liu Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients Br J Cancer 88 2003 1727 1733 (Pubitemid 36760417)
27. A.G. Saad, B.Y. Yeap, and F.B. Thunnissen Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma Cancer 113 2008 2129 2138
28. L. Prudkin, D.D. Liu, and N.C. Ozburn Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung Mod Pathol 22 2009 668 678
29. H. Grinberg-Rashi, E. Ofek, and M. Perelman The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain Clin Cancer Res 15 2009 1755 1761
30. K. Suyama, I. Shapiro, M. Guttman, and R.B. Hazan A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor Cancer Cell 2 2002 301 314 (Pubitemid 41043964)